The Ah receptor in stem cell cycling, regulation, and quiescence

Processes that regulate quiescence, self‐renewal, and differentiation of hematopoietic stem cells (HSCs) are not well understood. Owing, in part, to the ability of xenobiotic ligands to have persistent effects on the immune system in experimental animals, there has been much work to define a physiological role of the aryl hydrocarbon receptor (AhR) and its relationship to human disease. Persistent AhR activation by dioxin, a potent agonist, results in altered numbers and function of HSCs in mice. HSCs from AhR−/− knockout (KO) mice are hyperproliferative and have an altered cell cycle. Aging KO mice show characteristics consistent with premature bone marrow exhaustion. We propose that the increased proliferation of HSCs lacking AhR expression or activity is a result of loss of quiescence, and as such, AhR normally acts as a negative regulator to curb excessive or unnecessary proliferation. Similarly, prolonged and/or inappropriate stimulation of AhR activity may compromise the ability of HSCs to sense environmental signals that allow these cells to balance quiescence, proliferation, migration, and differentiation. These data and others support a hypothesis that deregulation of AhR function has an important role in HSC regulation and in the etiology and/or progression of certain hematopoietic diseases, many of which are associated with aging.

[1]  S. Welle,et al.  Loss of aryl hydrocarbon receptor promotes gene changes associated with premature hematopoietic stem cell exhaustion and development of a myeloproliferative disorder in aging mice. , 2014, Stem cells and development.

[2]  F. Quintana,et al.  Aryl Hydrocarbon Receptor Control of Adaptive Immunity , 2013, Pharmacological Reviews.

[3]  Nan Hao,et al.  The emerging roles of AhR in physiology and immunity. , 2013, Biochemical pharmacology.

[4]  A. Regev,et al.  Transcriptome Analysis Identifies Regulators of Hematopoietic Stem and Progenitor Cells , 2013, Stem cell reports.

[5]  G. Pei,et al.  Activation of Aryl Hydrocarbon Receptor (AhR) by Tranilast, an Anti-allergy Drug, Promotes miR-302 Expression and Cell Reprogramming* , 2013, The Journal of Biological Chemistry.

[6]  B. Baban,et al.  Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  G. van Zant,et al.  Concise Review: Hematopoietic Stem Cell Aging, Life Span, and Transplantation , 2012, Stem cells translational medicine.

[8]  T. Macdonald,et al.  The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis , 2012, Current opinion in gastroenterology.

[9]  E. Papoutsakis,et al.  The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis , 2012, Stem Cell Reviews and Reports.

[10]  D. Hinds,et al.  Current Status of the Epidemiologic Evidence Linking Polychlorinated Biphenyls and Non-Hodgkin Lymphoma, and the Role of Immune Dysregulation , 2012, Environmental health perspectives.

[11]  R. Fry,et al.  The Aryl Hydrocarbon Receptor Pathway: A Key Component of the microRNA-Mediated AML Signalisome , 2012, International journal of environmental research and public health.

[12]  R. Humphries,et al.  Concise Review: Multidimensional Regulation of the Hematopoietic Stem Cell State , 2012, Stem cells.

[13]  Bin Zhao,et al.  Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  T. Gasiewicz,et al.  Aryl Hydrocarbon Receptor Activation in Hematopoietic Stem/Progenitor Cells Alters Cell Function and Pathway-Specific Gene Modulation Reflecting Changes in Cellular Trafficking and Migration , 2011, Molecular Pharmacology.

[15]  June Li Quiescence regulators for hematopoietic stem cell. , 2011, Experimental hematology.

[16]  T. Gasiewicz,et al.  Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. , 2011, Stem cells and development.

[17]  D. Shepherd,et al.  Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Hui-yuan Shao,et al.  Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs. , 2011, Experimental and molecular pathology.

[19]  Anthony E. Boitano,et al.  Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells , 2010, Science.

[20]  S. Jackson,et al.  Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation , 2010, Science.

[21]  Juan Ma,et al.  Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. , 2010, Investigative ophthalmology & visual science.

[22]  N. Kerkvliet,et al.  Dioxin and immune regulation , 2010, Annals of the New York Academy of Sciences.

[23]  G. Huls,et al.  Paradoxical down-regulation of p16INK4a mRNA with advancing age in Acute Myeloid Leukemia , 2009, Aging.

[24]  S. Swain,et al.  Age-associated declines in immune system development and function: causes, consequences, and reversal. , 2009, Current opinion in immunology.

[25]  G. van Zant,et al.  Effects of aging on hematopoietic stem and progenitor cells. , 2009, Current opinion in immunology.

[26]  D. Allman Faculty Opinions recommendation of Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. , 2009 .

[27]  Motomi Osato,et al.  Stem cell exhaustion and leukemogenesis , 2009, Journal of cellular biochemistry.

[28]  C. Esser The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. , 2009, Biochemical pharmacology.

[29]  Y. Hirabayashi,et al.  Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells. , 2009, Biochemical pharmacology.

[30]  N. Kerkvliet AHR-mediated immunomodulation: the role of altered gene transcription. , 2009, Biochemical pharmacology.

[31]  Andreas Trumpp,et al.  Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.

[32]  O. Witte,et al.  Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf. , 2008, Genes & development.

[33]  J. Gaudet,et al.  Leukemia and hematopoietic stem cells: Balancing proliferation and quiescence , 2008, Cell cycle.

[34]  I. Weissman,et al.  Stems Cells and the Pathways to Aging and Cancer , 2008, Cell.

[35]  D. Scadden,et al.  Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation , 2008, Nature Reviews Genetics.

[36]  T. Gasiewicz,et al.  The Aryl Hydrocarbon Receptor Agonist 2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Circadian Rhythms, Quiescence, and Expression of Clock Genes in Murine Hematopoietic Stem and Progenitor Cells , 2006, Molecular Pharmacology.

[37]  M. Fraga,et al.  The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. , 2006, Carcinogenesis.

[38]  C. Shaw,et al.  Molecular Signatures of Proliferation and Quiescence in Hematopoietic Stem Cells , 2004, PLoS biology.

[39]  S. Gaskell,et al.  Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. , 2004, Blood.

[40]  T. Kajiume,et al.  TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  M. Tomonaga,et al.  Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. , 2003, Biochemical and biophysical research communications.

[42]  C Zocchetti,et al.  Health effects of dioxin exposure: a 20-year mortality study. , 2001, American journal of epidemiology.

[43]  J. Viel,et al.  Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. , 2000, American journal of epidemiology.

[44]  J. E. Staples,et al.  The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2000, Toxicology and applied pharmacology.

[45]  T. Gasiewicz,et al.  Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  J. E. Staples,et al.  Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. , 1998, Journal of immunology.

[47]  J. Sundberg,et al.  Lesions of Aryl-hydrocarbon Receptor–deficient Mice , 1997, Veterinary pathology.

[48]  Kenji Nakamura,et al.  Loss of teratogenic response to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD) in mice lacking the Ah (dioxin) receptor , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[49]  J. Reddy,et al.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Gasiewicz,et al.  Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1990, Journal of immunology.

[51]  S. Gaskell,et al.  reveals differences in expression of proteins regulating motility Comparative proteomics of primitive hematopoietic cell populations , 2013 .

[52]  T. Gasiewicz,et al.  Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. , 2009, Carcinogenesis.

[53]  Steven Henikoff,et al.  Nucleosome destabilization in the epigenetic regulation of gene expression , 2008, Nature Reviews Genetics.

[54]  M. Wright Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. , 1996, Human & experimental toxicology.

[55]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.